ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,651.00
11.50 (0.70%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  11.50 0.70% 1,651.00 1,651.00 1,652.00 1,656.00 1,637.00 1,650.50 4,661,376 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.80 68.01B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,639.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.01 billion. Gsk has a price to earnings ratio (PE ratio) of 13.80.

Gsk Share Discussion Threads

Showing 20101 to 20124 of 33100 messages
Chat Pages: Latest  808  807  806  805  804  803  802  801  800  799  798  797  Older
DateSubjectAuthorDiscuss
15/10/2019
16:10
Want more at under 16 but just had a few at 16.46
iknowverylittle
15/10/2019
16:08
Very tempted at the moment...
iknowverylittle
15/10/2019
15:52
GBP up, foreign earners down.
poikka
15/10/2019
15:49
However, this is looking grim …… ;0(
tradermichael
15/10/2019
14:37
Results are due in two weeks time so where is the share price leading to,GSK being the top faller today,Pfizer is not helping either .
abdullla
15/10/2019
11:49
I see Woodford Patient Capital is to be liquidated starting in January. But neither GSK nor AZN is in the top ten of its holdings so probably nothing to worry about for most.
grahamite2
14/10/2019
11:00
fwiw

CANTOR FITZGERALD RAISES GLAXOSMITHKLINE TO 'BUY' (HOLD) - TARGET 2000 (1450) PENCE

philanderer
14/10/2019
09:16
Keep watching while we make money:-)
abdullla
14/10/2019
08:23
Just watching. Interested when sub 15.
xxxxxy
11/10/2019
14:53
Good luck with those. You're right, it is a funny day.

GBP 1 = USD 1.27 now !

tradermichael
11/10/2019
14:44
Funny old day:-)
sold some blnd & bt
bought some bp & gsk

sicker
11/10/2019
13:16
Yes, all down to exchange rates today across the board.
philanderer
11/10/2019
11:43
What's POO doing today?

That might explain why Shell/BP havent moved downwards in similar fashion..
Poo >Sterling/USD$ move.

crossing_the_rubicon
11/10/2019
11:36
Rubicon

could be either of the reasons you suggest, although sales of Zantac ONLY represent a tiny proportion of overall GSK global sales.

If it's the GB Pound v US Dollar swing I would have expected to see a fall in other major dollar earners, like BP and Royal Dutch Shell.

GSK @ �16.50 must surely give a div yield of nearly 5% ??

ukneonboy
11/10/2019
11:02
I expect the buyers to reappear at 1650p
tradermichael
11/10/2019
10:59
GSK look cheap me - whatever has caused the fall today
ukneonboy
11/10/2019
10:22
Yes it looks that way
abdullla
11/10/2019
10:16
GBP up, foreign earners down.

Punctuation gremlin on ADFN.

poikka
11/10/2019
10:13
GSK down 2.8%, AZN down 2.6%. Isn't it the jump in sterling, from $1.22 to $1.25, caused by Johnson/Varadker 'progress'?
zho
11/10/2019
10:13
Back to mid 15�s in short order. The drop today is because of strengthening sterling and defensives being sold off on the back of a possible brexit deal and the end to this total sxxtshow.
porsche1945
11/10/2019
10:13
All the pharmas are down not just GSK
abdullla
11/10/2019
10:12
Abdul:

Thanks - I think the fall has been too quick, it has prompted me to buy back in.

tradermichael
11/10/2019
10:12
Also demonstrated in many, many clinical studies!!!

Re #102. Posts seem to have been renumbered!

alphorn
11/10/2019
10:11
Alphorn: I think its an overreaction. The change of manufacturing route gave rise to a trace impurity which is a known carcinogen. But there's unlikely to be a risk to patients in the short-term.

The active ingredient in Zantac (ranitidine) is safe as demonstrated in pre-clinical studies.

tradermichael
Chat Pages: Latest  808  807  806  805  804  803  802  801  800  799  798  797  Older

Your Recent History

Delayed Upgrade Clock